Celcuity Q3 2026 Results: Net Loss of $73.3M, Loss Widens
Celcuity Inc. reported a significant increase in total assets to $726.9 million as of September 30, 2026, driven by a substantial rise in investments and the addition of $50 million in intangible assets. The company is preparing for the commercialization of REVTORPYK (gedatolisib) and maintains a strong liquidity position with $642.7 million in cash, cash equivalents, and investments.
- Key figure
- Net loss $73.3M